Efficacy of a pectin-based anti-reflux agent on acid reflux and recurrence of symptoms and oesophagitis in gastro-oesophageal reflux disease

European Journal of Gastroenterology and Hepatology

Volumn 9, Issue 5, 1997, Pages 509-514

  Havelund, Troels ^a   Aalykke, Claus ^a   Rasmussen, Lars ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Clinical trial; Gastro oesophageal reflux disease; Heartburn; Oesophageal pH monitoring; Pectin; Recurrence

Indexed keywords

AFLURAX; IDOFLUX; OMEPRAZOLE; PECTIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ESOPHAGITIS; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; LIFE TABLE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; STANDING; STOMACH ACID; STOMACH PH; SUPINE POSITION;

EID: 0030910969     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199705000-00018     Document Type: Article

References (16)

1. Bianchi Porro G, Pace F: Rationale and efficacy of medical therapy for gastro-oesophageal reflux disease. J Intern Med 1993, 234:387-396.
2. Pope II CE: Acid-reflux disorders. New Engl J Med 1994, 331:656-660.
3. Moss HA, Washington N, Greaves JL, et al.: Anti-reflux agents: stratification or flotation? Eur J Gastroenterol Hepatol 1990, 2:45-51.
4. Washington N, Wilson CG, Greaves JL, et al.: An investigation into the floating behaviour of a pectin-containing anti-reflux formulation (FF5005) by means of gamma scintigraphy. Scand J Gastroenterol 1988, 23:920-924.
5. Bright-Asare P, Behar J, Brand DL, et al.: Effects of long term maintenance cimetidine therapy on gastroesophageal reflux disease. Gastroenterology 1982, 82:1025.
6. Kaul B, Petersen H, Erichsen E, et al.: Gastroesophageal reflux disease. Acute and maintenance treatments with cimetidine. Scand J Gastroenterol 1986, 21:139-145.
7. Klinkenberg-Knol EC, Festen HMP, Jansen JBMJ, et al.: Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann Intern Med 1994, 121:161-167.
8. Stanciu C, Bennett JR: Alginate/antacid in the reduction of gastro-oesophageal reflux. Lancet 1974, i:109-111.
9. Castell DO, Dalton CB, Becker D, et al.: Alginic acid decreases postprandial upright gastroesophageal reflux Dig Dis Sci 1992, 37:589-593.
10. Devis G, de Rop H, Peters O: Twenty-four-hour oesophageal pH monitoring of reflux episodes: effect of Algicon. Br J Clin Pract 1989, 43:15-17.
11. Hetzel DJ, Dent J, Reed WR, et al.: Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988, 95:903-912.
12. Poynard Y and a French Co-operative Study Group: Relapse rate of patients after healing of oesophagitis - a prospective study of alginate as self-care treatment for 6 months. Aliment Pharmacol Ther 1993, 7:385-392.
13. Koelz HR, Birchler A, Bretholz A, et al.: Healing and relapse of reflux esophagitis during treatment with ranitidine. Gastroenterology 1986, 91:1198-1205.
14. Bate CM, Booth SN, Crowe JP, et al.: Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Gut 1995, 36:492-498.
15. Dent J, Yeomans ND, Mackinnon M, et al.: Omeprazole v ranitidine for prevention of relapse in reflux esophagitis. A controlled double blind trial of their efficacy and safety Gut 1994, 35:590-598.
16. Laursen LS, Havelund T, Bondesen S, et al.: Omeprazole in the long term treatment of gastro-oesophageal reflux disease. A double-blind randomized dose finding study. Scand J Gastroenterol 1995, 30:839-846.